EUVIMEDEUVIMED entdecken
Open Access

Elucidating the Mechanism of Action of the Gram-Negative-Pathogen-Selective Cyclic Antimicrobial Lipopeptide Brevicidine

Xinghong Zhao iD, Xinyi Zhong, Shinong Yang, Kai Deng, Lu Liu, Xu Song, Yuanfeng Zou, Lixia Li, Xun Zhou, Renyong Jia, Juchun Lin, Huaqiao Tang iD und 7 weitere

Antimicrobial Agents and Chemotherapy · 2023

DOI: 10.1128/aac.00010-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Xinghong Zhao und 18 weiteren Autor:innen. Beteiligte Einrichtung: Lab for Sustainable Antimicrobials, Department of Pharmacy, Sichuan Agricultural University, Chengdu, China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Enterobacteriaceae. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Sichuan Science and Technology Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Due to the accelerated appearance of antimicrobial-resistant (AMR) pathogens in clinical infections, new first-in-class antibiotics, operating via novel modes of action, are desperately needed. Brevicidine, a bacterial nonribosomally produced cyclic lipopeptide, has shown potent and selective antimicrobial activity against Gram-negative pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsEnterobacteriaceaeAnimalsMiceBacteriaLipopeptidesMicrobial Sensitivity TestsGram-Negative Bacteria

Stichwörter der Autor:innen

Escherichia coliantimicrobial mechanismantimicrobial resistancebacteremia modelbrevicidine

Substanzen

Anti-Bacterial AgentsLipopeptides

Autor:innen und Institutionen

  • Lab for Sustainable Antimicrobials, Department of Pharmacy, Sichuan Agricultural University, Chengdu, China.
  • Department of Molecular Genetics, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Groningen, The Netherlands.
  • Key Laboratory of Animal Disease and Human Health of Sichuan Province, Sichuan Agricultural University, Chengdu, China.
  • State Key Laboratory of Crop Gene Exploration and Utilization in Southwest China, Sichuan Agricultural University at Wenjiang, Chengdu, Sichuan, China.

ORCID-Profile: Xinghong Zhao, Huaqiao Tang, Oscar P Kuipers

Förderung

  • Sichuan Science and Technology Program
  • National Natural Science Foundation of China

Zitieren

APA

Zhao, X., Zhong, X., Yang, S., Deng, K., Liu, L., Song, X., Zou, Y., Li, L., Zhou, X., Jia, R., Lin, J., Tang, H., Ye, G., Yang, J., Zhao, S., Lang, Y., Wan, H., Yin, Z., & Kuipers, O. P. (2023). Elucidating the Mechanism of Action of the Gram-Negative-Pathogen-Selective Cyclic Antimicrobial Lipopeptide Brevicidine. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00010-23

Vancouver

Zhao X, Zhong X, Yang S, Deng K, Liu L, Song X, et al. Elucidating the Mechanism of Action of the Gram-Negative-Pathogen-Selective Cyclic Antimicrobial Lipopeptide Brevicidine. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.00010-23

BibTeX
@article{Zhao2023,
  author = {Zhao, Xinghong and Zhong, Xinyi and Yang, Shinong and Deng, Kai and Liu, Lu and Song, Xu and Zou, Yuanfeng and Li, Lixia and Zhou, Xun and Jia, Renyong and Lin, Juchun and Tang, Huaqiao and Ye, Gang and Yang, Jianqing and Zhao, Shan and Lang, Yifei and Wan, Hongping and Yin, Zhongqiong and Kuipers, Oscar P},
  title = {Elucidating the Mechanism of Action of the Gram-Negative-Pathogen-Selective Cyclic Antimicrobial Lipopeptide Brevicidine},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2023},
  doi = {10.1128/aac.00010-23}
}
Kostenlos starten →